Are Poly Medicure Ltd latest results good or bad?

Poly Medicure Ltd's latest financial results for Q4 FY26 present a complex picture. The company reported a significant year-on-year revenue growth of 21.25%, reaching ₹534.51 crores, marking the highest quarterly revenue in its history. However, this revenue growth did not translate into profit, as net profit fell by 27.81% to ₹66.29 crores compared to the same quarter last year. The operating margin, excluding other income, contracted to 20.65%, which is the lowest level in the last eight quarters, down from 27.10% in the previous year. This decline in operating margin indicates challenges in maintaining operational efficiency despite the revenue increase. Additionally, the profit after tax (PAT) margin also saw a notable decline, dropping to 12.17% from 20.83% a year earlier, reflecting a significant deterioration in profitability. The financial data highlights that while Poly Medicure achieved substantial sales growth, it faced severe cost pressures, particularly in employee costs, which surged nearly 60% year-on-year. This cost inflation has raised concerns about the company's ability to manage expenses effectively in a competitive healthcare devices market. Overall, the results suggest that Poly Medicure is grappling with operational challenges that have overshadowed its revenue achievements. The company saw an adjustment in its evaluation, reflecting these underlying issues. Investors may need to closely monitor future performance to assess whether the company can address its profitability challenges and improve operational efficiency in the coming quarters.